Galanis E - Search Results

1

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

James CD, Galanis E, Frederick L, Kimmel DW, Cunningham JM, Atherton-Skaff PJ, O'Fallon JR, Jenkins RB, Buckner JC, Hunter SB, Olson JJ, Scheithauer BW. James CD, et al. Among authors: galanis e. Int J Oncol. 1999 Sep;15(3):547-53. doi: 10.3892/ijo.15.3.547. Int J Oncol. 1999. PMID: 10427138 Clinical Trial.

2

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

Galanis E, Buckner J, Kimmel D, Jenkins R, Alderete B, O'Fallon J, Wang CH, Scheithauer BW, James CD. Galanis E, et al. Int J Oncol. 1998 Oct;13(4):717-24. Int J Oncol. 1998. PMID: 9735401

3

Management of recurrent meningeal hemangiopericytoma.

Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG. Galanis E, et al. Cancer. 1998 May 15;82(10):1915-20. Cancer. 1998. PMID: 9587125 Clinical Trial.

4

Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.

Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O'Fallon JR, Farr G Jr. Galanis E, et al. J Neurosurg. 1998 Sep;89(3):425-30. doi: 10.3171/jns.1998.89.3.0425. J Neurosurg. 1998. PMID: 9724117 Clinical Trial.

5

Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.

Galanis E, Buckner JC, Burch PA, Schaefer PL, Dinapoli RP, Novotny PJ, Scheithauer BW, Rowland KM, Vukov AM, Mailliard JA, Morton RF. Galanis E, et al. J Clin Oncol. 1998 Sep;16(9):2953-8. doi: 10.1200/JCO.1998.16.9.2953. J Clin Oncol. 1998. PMID: 9738563 Clinical Trial.

6

Chemotherapy for high-grade gliomas.

Galanis E, Buckner J. Galanis E, et al. Br J Cancer. 2000 Apr;82(8):1371-80. doi: 10.1054/bjoc.1999.1075. Br J Cancer. 2000. PMID: 10780513 Free PMC article. Review. No abstract available.

7

Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas.

Galanis E, Buckner JC, Novotny P, Morton RF, McGinnis WL, Dinapoli R, Schomberg P, O'Fallon JR. Galanis E, et al. J Neurosurg. 2000 Aug;93(2):201-7. doi: 10.3171/jns.2000.93.2.0201. J Neurosurg. 2000. PMID: 10930004

8

Chemotherapy of brain tumors.

Galanis E, Buckner JC. Galanis E, et al. Curr Opin Neurol. 2000 Dec;13(6):619-25. doi: 10.1097/00019052-200012000-00002. Curr Opin Neurol. 2000. PMID: 11148660 Review.

9

Effective chemotherapy for advanced CNS embryonal tumors in adults.

Galanis E, Buckner JC, Schomberg PJ, Hammack JE, Raffel C, Scheithauer BW. Galanis E, et al. J Clin Oncol. 1997 Aug;15(8):2939-44. doi: 10.1200/JCO.1997.15.8.2939. J Clin Oncol. 1997. PMID: 9256138

10

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.

Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Galanis E, et al. Hum Gene Ther. 2001 May 1;12(7):811-21. doi: 10.1089/104303401750148766. Hum Gene Ther. 2001. PMID: 11339897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page